A comparison of radiation treatment plans using IMRT with helical tomotherapy and 3D conformal radiotherapy for nasal natural killer/T-cell lymphoma

British Journal of Radiology

Volumn 82, Issue 981, 2009, Pages 756-763

  Tomita, Natsuo ^a   Kodaira, T ^a   Tachibana, H ^a   Nakamura, T ^a   Nakahara, R ^a   Inokuchi, H ^a   Mizoguchi, N ^a   Takada, A ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX; NK T CELL LYMPHOMA; NOSE CAVITY; ORGAN; PALATE; PRESCRIPTION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RISK; THREE DIMENSIONAL IMAGING; TOMOTHERAPY; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; CLINICAL PROTOCOLS; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; JAPAN; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; NASAL CAVITY; NOSE NEOPLASMS; PILOT PROJECTS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349097703     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/83758373     Document Type: Article

References (33)

1. Ribrag V, Ell Hajj M, Janot F, Girinsky T, Domenge C, Schwaab G, et al. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia 2001;15:1123-1126 (Pubitemid 32717284)
2. Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 2004;15:1467-1475 (Pubitemid 39409735)
3. Kim WS, Song SY, Ahn YC, Ko YH, Baek CH, Kim DY, et al. CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol 2001;12:349-352
4. Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, et al. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy. Oral Oncol 2008;44:23-30. (Pubitemid 350251276)
5. Al-Hakeem DA, Fedele S, Carlos R, Porter S. Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol 2007;43:4-14. (Pubitemid 46162254)
6. Koom WS, Chung EJ, Yang WI, Shim SJ, Suh CO, Roh JK, et al. Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints. Int J Radiat Oncol Biol Phys 2004;59:1127-1137
7. Shikama N, Ikeda H, Nakamura S, Oguchi M, Isobe K, Hirota S, et al. Localized aggressive non-Hodgkin's lymphoma of the nasal cavity: a survey by the Japan Lymphoma Radiation Therapy Group. Int J Radiat Oncol Biol Phys 2001;51:1228-1233 (Pubitemid 33116315)
8. Li YX, Yao B, Jin J, Wang WH, Liu YP, Song YW, et al. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol 2006;24:181-189 (Pubitemid 46630511)
9. Isobe K, Uno T, Tamaru J, Kawakami H, Ueno N, Wakita H, et al. Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters. Cancer 2006;106:609-615 (Pubitemid 43157624)
10. Sakata K, Fuwa N, Kodaira T, Aratani K, Ikeda H, Takagi M, et al. Analyses of dose-response in radiotherapy for patients with mature T/NK-cell lymphomas according to the WHO classification. Radiother Oncol 2006;79:179-184 (Pubitemid 43867811)
11. Claus F, Duthoy W, Boterberg T, De Gersem W, Huys J, Vermeersch H, et al. Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience. Oral Oncol 2002;38:597-604. (Pubitemid 34880121)
12. Urbano TG, Clark CH, Hansen VN, Adams EJ, Miles EA, Mc Nair H, et al. Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study. Radiother Oncol 2007;85:58-63. (Pubitemid 47562585)
13. De Meerleer GO, Fonteyne VH, Vakaet L, Villeirs GM, Denoyette L, Verbaeys A, et al. Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control. Radiother Oncol 2007;82:160-166 (Pubitemid 46298776)
14. Jeraj R, Mackie TR, Balog J, Olivera G, Pearson D, Kapatoes J, et al. Radiation characteristics of helical tomotherapy. Med Phys 2004;31:396-404.
15. Welsh JS, Patel RR, Ritter MA, Harari PM, Mackie TR, Mehta MP. Helical tomotherapy: an innovative technology and approach to radiation therapy. Technol Cancer Res Treat 2002;1:311-316
16. Kapatoes JM, Olivera GH, Reckwerdt PJ, Fitchard EE, Schloesser EA, Mackie TR. Delivery verification in sequential and helical tomotherapy. Phys Med Biol 1999;44:1815-1841
17. Kapatoes JM, Olivera GH, Ruchala KJ, Smilowitz JB, Reckwerdt PJ, Mackie TR. A feasible method for clinical delivery verification and dose reconstruction in tomotherapy. Med Phys 2001;28:528-542
18. Lymphoid neoplasms. In: American Joint Committee on Cancer: AJCC Cancer Staging Manual. 6th edn. New York, NY: Springer, 2002: 393-406.
19. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-3849 (Pubitemid 30017051)
20. Radiation Therapy Oncology Group (RTOG) 0615. Available from: http://www.rtog.org/members/protocols/0615/0615.pdf [Accessed 11 February 2009].
21. Cox JD, Ang KK, editors. Radiation Oncology: Rationale, Technique, Results. 8th edn. Philadelphia, USA: 2003.
22. Scholz C, Schulze C, Oelfke U, Bortfeld T. Development and clinical application of a fast superposition algorithm in radiation therapy. Radiother Oncol 2003;69:79-90. (Pubitemid 37351021)
23. International Commission on Radiation Units and Measurements. ICRU Report 62: Prescribing, recording, and reporting photon beam therapy (Supplement to ICRU Report 50). Bethesda, MD: ICRU, 1999.
24. Longobardi B, De Martin E, Fiorino C, Dell'oca I, Broggi S, Cattaneo GM, et al. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques. Radiother Oncol 2005;77:148-156
25. Hermanto U, Frija EK, Lii MJ, Chang EL, Mahajan A, Woo SY. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys 2007;67:1135-1144
26. Mock U, Georg D, Bogner J, Auberger T, Potter R. Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 2004;58:147-154 (Pubitemid 38010348)
27. Huang D, Xia P, Akazawa P, Akazawa C, Quivey JM, Verhey LJ, et al. Comparison of treatment plans using intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 2003;56:158-168 (Pubitemid 36403687)
28. Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006;66:981-991
29. Yamaguchi M, Ogawa S, Nomoto Y, Oka K, Taniguchi M, Nakase K, et al. Treatment outcomes of nasal NK-cell lymphoma: a report of 12 consecutively-diagnosed cases and a review of the literature. J clin Exp Hematop 2001;41:93-99.
30. Suzuki R, Takeuchi K, Ohshima K, Nakamura S. Extranodal NK/T-cell lymphoma: diagnosis and treatment cues. Hematol Oncol 2008;26:66-72. (Pubitemid 351951334)
31. Huang MJ, Jiang Y, Liu WP, Li ZP, Li M, Zhou L, et al. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 2008;70:166-174 (Pubitemid 350251036)
32. Kodaira T, Tomita N, Tachibana H, Nakamura T, Nakahara R, Inokuchi H, et al. Aichi Cancer Center initial experience of intensity modulated radiation therapy for nasopharyngeal cancer using helical tomotherapy. Int J Radiat Oncol Biol Phys 2009;73:1129-1134
33. Sheng K, Molloy JA, Larner JM, Read PW. A dosimetric comparison of non-coplanar IMRT versus Helical Tomotherapy for nasal cavity and paranasal sinus cancer. Radiother Oncol 2007;82:174-178 (Pubitemid 46275139)